Neurosurgical Treatment of Breast Cancer Metastases to the Neurocranium

Abstract EN

Breast cancer metastases to the neurocranium might involve the bone, the dura, or the brain parenchyma.

The latter location is the far most common.

The annual incidence of brain metastases in patients with breast cancer is in the range of 4–11 per 100.000 persons per year.

Symptoms and findings mainly result from the location of the lesion.

The diagnostic method of choice is magnetic resonance imaging before and after administration of contrast material.

Breast cancer brain metastases present as solid, cystic, or partially cystic lesions with marked contrast enhancement and perilesional edema.

The therapeutic option of choice is microsurgical resection whenever possible.

Adjuvant treatment includes radiotherapy, radiosurgery, and/or chemotherapy.